跳轉至內容
Merck
全部照片(1)

重要文件

20029-U

Supelco

ORBO Amberlite XAD-4 管

RC,GFF,F,F (specially cleaned) separators, O.D. × L 13-8 mm × 75 mm , OSHA Versatile Sampler (OVS), pkg of 10 ea

同義詞:

ORBO-65P OVS 氟化物管, 带玻璃纤维过滤器

登入查看組織和合約定價


About This Item

分類程式碼代碼:
12190000
NACRES:
NB.24
暫時無法取得訂價和供貨情況

材料

RC,GFF,F,F (specially cleaned) separators

品質等級

產品線

Amberlite
ORBO

成份

Bed A, 160 mg
Bed B, 80 mg

包裝

pkg of 10 ea

製造商/商標名

ORBO 65P

技術

active air sampling: suitable

外徑 × 長度

13-8 mm × 75 mm , OSHA Versatile Sampler (OVS)

基質

XAD-4 (specially cleaned)

應用

air monitoring
environmental
industrial hygiene

相容性

for sampling Polar and non-polar VOCs; select aldehydes

尋找類似的產品? 前往 產品比較指南

一般說明

ORBO 65P OSHA Versatile Sampler (OVS) is used for sampling both polar and non-polar volatile organic compounds (VOCs). It is particularly suitable for selecting aldehydes. The product is capped at the inlet and outlet to minimize environmental exposure.
It is commonly used as an adsorbent to collect and retain the volatile organic compound in the air samples, allowing for accurate determination of air concentrations. [1]

法律資訊

Amberlite is a trademark of DuPont de Nemours, Inc.
ORBO is a trademark of Sigma-Aldrich Co. LLC
XAD is a registered trademark of The Dow Chemical Company or an affiliated company of Dow

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable


從最近期的版本中選擇一個:

分析證明 (COA)

Lot/Batch Number

抱歉,我們目前沒有在線上提供本產品的COA

如果您需要協助,請聯絡 客戶支援

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Perfluorooctanesulfonate (PFOS) Conversion from N-Ethyl-N-(2-hydroxyethyl)-perfluorooctanesulfonamide (EtFOSE) in male Sprague Dawley rats after inhalation exposure.
Sue C, et al.
Environmental Research, 155, 307-313 (2017)
A Orbo et al.
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 117(7), 972-976 (1997-03-10)
The development of female steroid hormone-related neoplasms such as gynaecologic and mammary cancers is influenced by hormones administered exogenously. Hormonal contraceptives and hormone replacement therapy both affect the risk of developing cancers in the endometrium, cervix, ovarium, and mammary glands.
Bjørn T Moe et al.
Anticancer research, 29(4), 1047-1052 (2009-05-06)
Endometrial hyperplasia is a precursor lesion of endometrial carcinoma. Clinical studies of endometrial hyperplasia have shown that levonorgestrel (LNG) is more therapeutically effective than medroxyprogesterone acetate (MPA). The present pharmacological in vitro study was performed to compare progestin effects on
K Flo et al.
Scandinavian journal of clinical and laboratory investigation, 55(8), 715-721 (1995-12-01)
Elevated extracellular cGMP levels have been observed in various clinical conditions, and the analyte has been proposed as a diagnostic marker of cardiovascular as well as malignant diseases. However, the use of extracellular cGMP as a pathophysiological marker requires detailed
Anne Ørbo et al.
The Journal of steroid biochemistry and molecular biology, 113(1-2), 139-149 (2009-01-14)
Patients with endometrial hyperplasia representing preliminary stages of endometrial cancer have shown to respond to therapy in 100% of the cases when treated with levonorgestrel-impregnated intrauterine device. Anti-proliferative effect has also been reported after application of an anti-progestin impregnated intrauterine

Questions

Reviews

No rating value

Active Filters

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務